SNY:NASDAQ
Sanofi SA
$42.50
arrow_upward
+0.05%(+0.020) 1D
$42.35
arrow_downward
-0.35% (-0.15)todayPre-market
Closed: Sep 21, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SNY...
Open
$42.64
High
$42.78
Low
$42.47
Mkt. cap
102.67B
Avg. vol.
2.32M
Volume
587.00
Dividend
5.69%
Quarterly dividend
$0.60
Ex-dividend date
May 5, 2026
P/E ratio
22.70
52-wk high
$52.68
52-wk low
$40.89
EPS
$1.87
Beta
0.38
Shares outstanding
2.42B
No. of employees
75K
Open
$42.64
High
$42.78
Low
$42.47
Mkt. cap
102.67B
Avg. vol.
2.32M
Volume
587.00
Dividend
5.69%
Quarterly dividend
$0.60
Ex-dividend date
May 5, 2026
P/E ratio
22.70
52-wk high
$52.68
52-wk low
$40.89
EPS
$1.87
Beta
0.38
Shares outstanding
2.42B
No. of employees
75K
News stories
From web sources and news partners
AD HOC NEWS
·
30 minutes ago
Sanofi stock steadies near EUR 74 as earnings and pipeline weigh
Reuters
·
1 month ago
Sanofi drug pipeline worries, Dupixent dependence shake shares
Profile
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
About Sanofi SA
CEOBelén Garijo | Paul Hudson
Employees74.8K
Founded1973
HeadquartersParis, ÃŽle-de-France, France
SectorPharmaceutical industry
Websitesanofi.com